Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance

doi:10.5306/wjco.v15.i5.614

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1416)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

HTML

863

Figures (1-5)

135

Tables (1-4)

131

Sum=1168

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

165

Sum=204

May 24, 2024 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. May 24, 2024; 15(5): 614-634
Published online May 24, 2024. doi: 10.5306/wjco.v15.i5.614

Table 4 Univariate and multivariate analyses for the predictors of disease recurrence in patients with lung squamous cell carcinoma

Characteristic	Univariate analysis, OR (95%CI)	P value	Multivariate analysis, OR (95%CI)	P value
Age
< 60	1	-
60-69	1.87 (0.97-3.58)	0.06
≥ 70	2.45 (0.89-6.72)	0.082
Tumor location
Peripheral	1	-	1	-
Central	1.86 (0.99-3.47)	0.052^a	1.04	0.92
Histology
KSCC	1	-
NKSCC	1.79 (0.94-3.38)	0.075
Tumor grade
G1	1	-	1	-
G2	1.51 (0.76-2.95)	0.232	1.36 (0.59-3.01)	0.466
G3	3.44 (1.39-8.48)	0.007^a	4.24 (1.37-13.14)	0.001^a
T stage
T1a	1	-
T1b	7.00 (1.04-46.95)	0.045^a
T2a	4.26 (0.83-21.74)	0.082
T2b	5.00 (0.79-31.62)	0.087
T3	3.38 (0.65-17.69)	0.149
N stage
N0	1	-	1	-
N1	2.00 (0.97-4.11)	0.059	1.89 (0.81-4.39)	0.137
N2	3.22 (1.37-7.57)	0.007^a	3.43 (1.26-9.34)	0.016^a
Stage
I	1	-	1	-
II	2.17 (0.89-5.27)	0.088	1.87 (0.45-7.69)	0.385
III	3.13 (1.29-7.60)	0.012^a	3.44 (0.50-23.49)	0.207
Adjuvant therapy
Radiation therapy	1	-	1	-
Chemo- and radiotherapy	1.41 (0.50-3.97)	0.513	0.57 (0.16-1.98)	0.376
Chemotherapy	3.02	0.008	2.07 (0.78-5.53)	0.146
DCs with weak expression of CD34
Absence	1	-	1	-
Presence	4.26 (2.25-8.05)	0.0000^a	1.18 (0.43-3.23)	0.749
Contact-type DCs
Absence	1	-
Presence	0.97 (0.54-1.75)	0.934
The capillaries in the tumor solid component
Absence	1	-	1	-
Presence	2.32 (1.24-4.35)	0.008^a	1.20 (0.56-2.59)	0.638
LFFCT in the tumor stroma
Absence	1	-	1	-
Presence	6.24 (2.85-13.67)	0.0000^a	7.34 (3.03-17.76)	0.0000^a
Fragmentation of the tumor solid component
Absence	1	-	1	-
Presence	3.03 (1.58-5.82)	0.0009^a	5.23 (2.27-12.07)	0.0001^a
Retraction clefts
Absence	1	-
Presence	0.71 (0.38-1.29)	0.262
Tumor spread through the AASs
Presence	1	-	1	-
Absence	2.06 (1.13-3.76)	0.019^a	3.37 (1.22-5.66)	0.0083^a

^aP < 0.05, the differences between groups are statistically significant.

AASs: Alveolar air spaces; DCs: Dilated capillaries; KSCC: Keratinizing squamous cell carcinoma; LFFCT: Loose, fine fibrous connective tissue in the tumor stroma; NKSCC: Nonkeratinizing squamous cell carcinoma; OR: Odds ratio; CD34: Cluster of differentiation 34.

Citation: Senchukova MA, Kalinin EA, Volchenko NN. Different types of tumor microvessels in stage I-IIIA squamous cell lung cancer and their clinical significance. World J Clin Oncol 2024; 15(5): 614-634
URL: https://www.wjgnet.com/2218-4333/full/v15/i5/614.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i5.614